NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=88033&from=3 DEADLINE: July 12, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/? id=88033&from=3 CONTACT US HERE: ALLEGATIONS: The complaint a ...

NEW YORK, June 28, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). Shareholders who purchased shares of NARI during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=87810&from=4 ALLEGATIONS: The complaint alleges that dur ...

Class Period: Feb. 24, 2022 – Feb. 28, 2024 Lead Plaintiff Deadline: July 12, 2024 Visit: www.hbsslaw.com/investor-fraud/nari Contact the Firm Now: NARI@hbsslaw.com 844-916-0895 Inari Medical, Inc. (NASDAQ: NARI), a leading medical device manufacturer, finds itself embroiled in a complex legal battle as the U.S. Department of Justice (DOJ) intensifies its scrutiny. The investigation centers on allegations of illicit kickbacks to healthcare professionals, a revelation that has sent shockwaves through the com ...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Inari Medical To Contact Him Directly To Discuss Their Options Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP)Faruqi & Faruqi Logo (PRNewsfoto/Faruqi & Faruqi, LLP) On February 28, 2024, Inari Medical released its financial results for the fourth quarter and the full year of 2023. The Company also announced that it had received a civil investigative demand from the US ...

CONTACT US HERE: DEADLINE: July 12, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/? id=87098&from=4 NEW YORK, June 25, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). CLASS PERIOD: March 10, 2021 to February 28, 2024 WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action l ...

DETAILS OF THE CASE: According to the lawsuit, defendants throughout the Class Period touted Inari's "record revenue," purportedly driven by "the strength in our core [venous thromboembolism] ("VTE") business." But defendants failed to disclose that a significant portion of its expenses were used to compensate medical professionals improperly for using Inari's products. In truth, while defendants were speaking positively about Inari Medical's growth prospects, it had been engaging in illegal business practi ...

Core Viewpoint - A class action lawsuit has been filed against Inari Medical, Inc. for failing to disclose potential negative impacts on its financial results due to alleged bribes and kickbacks [2] Group 1: Company Overview - Inari Medical, Inc. specializes in developing, manufacturing, and commercializing catheter-based technologies for treating venous thromboembolism (VTE) [1] Group 2: Allegations and Impact - The lawsuit alleges that Inari failed to disclose a civil investigative demand from the U.S. Department of Justice regarding payments to healthcare professionals, which could materially impact its business [2] - Following the disclosure on February 29, 2024, Inari's stock price fell by over $12 per share, or 21%, closing at $46.12 [2] Group 3: Legal Proceedings - Shareholders wishing to serve as lead plaintiffs must file motions by July 12, 2024, and can remain absent class members if they choose not to participate [3]

On February 29, 2024, Inari announced that it had received a civil investigative demand from the U.S. Department of Justice "in connection with an investigation under the federal Anti-Kickback Statute and Civil False Claims Act" requesting information and documents "primarily relating to meals and consulting service payments provided to health care professionals." LOS ANGELES, June 20, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming July 12, 2024 deadline to fi ...

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP: Do you, or did you, own shares of Inari Medical, Inc. (NASDAQ: NARI)? Did you purchase your shares between March 10, 2021 and February 28, 2024, inclusive? Did you lose money in your investment in Inari Medical, Inc.? Do you want to discuss your rights? Bernstein Liebhard LLP announces that a new class action expanding the class period has been filed against Inari Medical, Inc. ("Inari" or the "Company") (NASDAQ: NARI). The new case alleges ...

NEW YORK, June 20, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Inari Medical, Inc. (NASDAQ: NARI). https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/?id=86288&from=4 DEADLINE: July 12, 2024 Shareholders should not delay in registering for this class action. Register your information here: https://securitiesclasslaw.com/securities/inari-medical-inc-loss-submission-form/? id=86288&from=4 SOURCE Gross Law Firm CONTACT US HERE: ALLEGATION ...